Skip to Main Content

Paper Details

Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B.
Pathogens and Immunity
19
2019
A DS-Cav1 immunogen, B18537 F, Cav1, Cav1 F, DS-Cav1, DS-Cav1 mutations, DS-Cav1-Stabilized Fusion Glycoprotein, RSV, Respiratory Syncytial Virus, Respiratory Syncytial Virus Subtype B, Respiratory syncytial virus, alpha, alpha-carbon, antigenic site, humans, prefusion, subtype A RSV fusion (F) glycoprotein, subtype A prefusion F, trimer
Author NameAffiliation
Michael G JoyceVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Michael G JoyceHenry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Ivelin S GeorgievVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Ivelin S GeorgievVanderbilt University Medical Center
Ivelin S GeorgievVanderbilt University Medical Center
Ivelin S GeorgievVanderbilt University
Aliaksandr DruzVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Yongping YangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Baoshan ZhangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Gwo-Yu ChuangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Jason S McLellanVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Jason S McLellanCollege of Natural Sciences, The University of Texas at Austin
John R MascolaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 14

Datasets

Release 1.2